Literature DB >> 7691731

Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.

M Dohlsten1, M Björklund, A Sundstedt, G Hedlund, D Samson, T Kalland.   

Abstract

The response of mouse T cells to the superantigen staphylococcal enterotoxin A (SEA) requires 1000-fold higher concentrations compared to human T cells. In order to develop a sensitive model for SEA studies in mice, the immunopharmacology has been studied in T-cell receptor (TcR) V beta 3 transgenic (TGV beta 3) and non-transgenic (non-TG) C57Bl/6 mice. The frequency of SEA-responsive T cells in the TGV beta 3 mice exceeded 90%, whereas a 10-fold lower frequency was seen in normal C57Bl/6 mice. Nanograms of SEA injected intravenously into TGV beta 3 mice induced strong cytolytic T lymphocyte (CTL) activity against SEA-coated major histocompatibility complex (MHC) class II+ B-lymphoma cells, whereas administration of 1000-fold higher amounts of SEA to non-TG littermates or normal C57Bl/6 mice induced only a moderate response. Kinetic analysis demonstrated that the CTL activity was more rapidly detectable in TG mice, but substantial levels were seen 2 days after SEA injection in both TGV beta 3 and non-TG mice. The cytotoxic T-cell response induced by SEA in TGV beta 3 and non-TG mice was completely MHC class II dependent, as SEA-coated MHC class II-transfected syngeneic B16 melanoma cells but not untransfected B16 cells were sensitive to lysis. Large amounts of tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) accumulated in serum of TGV beta 3 mice after injection of 10 ng SEA, whereas only marginal amounts were recorded in non-TG even after injection of 100 micrograms SEA. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis demonstrated that SEA-induced TNF-alpha and IFN-gamma mRNA reached maximal levels 1 hr after SEA administration in TGV beta 3 mice, whereas peak serum levels of TNF-alpha and IFN-gamma proteins were recorded after 2 hr. Comparison of the mRNA levels of a panel of cytokines in the TGV beta 3 and non-TG mice revealed that almost similar amounts of interleukin-1 (IL-1) were induced in both strains, whereas IL-4 was only detected at significant levels in the TGV beta 3 mouse. The results suggest that TGV beta 3 mice are suitable for studying in vivo immune responses to superantigens at concentrations comparable to the potent effects elicited in humans. Moreover, this model is useful for detailed studies on the dynamic regulation of T-cell activation and anergy induced by superantigens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691731      PMCID: PMC1421909     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  48 in total

1.  A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells.

Authors:  G Hedlund; M Dohlsten; T Herrmann; G Buell; P A Lando; S Segrén; J Schrimsher; H R MacDonald; H O Sjögren; T Kalland
Journal:  J Immunol       Date:  1991-12-15       Impact factor: 5.422

Review 2.  Selective elements for the V beta region of the T cell receptor: Mls and the bacterial toxic mitogens.

Authors:  C A Janeway
Journal:  Adv Immunol       Date:  1991       Impact factor: 3.543

3.  High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR.

Authors:  J D Fraser
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

4.  Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines.

Authors:  H Fischer; M Dohlsten; M Lindvall; H O Sjögren; R Carlsson
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

5.  Interferon-gamma and growth factor production by murine T cells derived from three different lymphoid tissues.

Authors:  I Höidén; G Möller
Journal:  Eur J Immunol       Date:  1991-11       Impact factor: 5.532

6.  Direct effects of purified staphylococcal toxic shock syndrome toxin 1 on myocardial function of isolated rabbit atria.

Authors:  R D Olson; D L Stevens; M E Melish
Journal:  Rev Infect Dis       Date:  1989 Jan-Feb

7.  Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR.

Authors:  A Herman; N Labrecque; J Thibodeau; P Marrack; J W Kappler; R P Sekaly
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

8.  Frequencies of IL-2- and IL-4-secreting T cells in naive and antigen-stimulated lymphocyte populations.

Authors:  G D Powers; A K Abbas; R A Miller
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

9.  The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice.

Authors:  J White; A Herman; A M Pullen; R Kubo; J W Kappler; P Marrack
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

10.  Characterization of T helper 1 and 2 cell subsets in normal mice. Helper T cells responsible for IL-4 and IL-5 production are present as precursors that require priming before they develop into lymphokine-secreting cells.

Authors:  S L Swain; D T McKenzie; A D Weinberg; W Hancock
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

View more
  18 in total

1.  Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses.

Authors:  M J Litton; M Dohlsten; J Hansson; A Rosendahl; L Ohlsson; T Kalland; J Andersson; U Andersson
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivo.

Authors:  H Belfrage; M Dohlsten; G Hedlund; T Kalland
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

Review 3.  Genetically engineered superantigens in experimental tumor therapy.

Authors:  P Antonsson; J Hansson; T Kalland; P A Lando; L Ohlsson; E Schad; A Svensson; M Dohlsten
Journal:  Springer Semin Immunopathol       Date:  1996

4.  Genetically engineered superantigens as tolerable antitumor agents.

Authors:  J Hansson; L Ohlsson; R Persson; G Andersson; N G Ilbäck; M J Litton; T Kalland; M Dohlsten
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

5.  Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice.

Authors:  Govindarajan Rajagopalan; Koji Iijima; Manisha Singh; Hirohito Kita; Robin Patel; Chella S David
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

6.  Overexpression of the T-cell receptor V beta 3 in transgenic mice increases mortality during infection by enterotoxin A-producing Staphylococcus aureus.

Authors:  Y X Zhao; A Abdelnour; T Kalland; A Tarkowski
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

7.  A role for perforin in downregulating T-cell responses during chronic viral infection.

Authors:  M Matloubian; M Suresh; A Glass; M Galvan; K Chow; J K Whitmire; C M Walsh; W R Clark; R Ahmed
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  In vivo anergized CD4+ T cells express perturbed AP-1 and NF-kappa B transcription factors.

Authors:  A Sundstedt; M Sigvardsson; T Leanderson; G Hedlund; T Kalland; M Dohlsten
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

9.  Superantigens anergize cytokine production but not cytotoxicity in vivo.

Authors:  A Sundstedt; M Dohlsten; G Hedlund; I Höidén; M Björklund; T Kalland
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

10.  T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.

Authors:  A Sundstedt; S Grundström; M Dohlsten
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.